leukemia
The company believes that it has threaded the needle in terms of providing the maximum of necessary information to clinicians, while maintaining a rapid turnaround time.
Invivoscribe LeukoStrat CDx Gets CE Mark, EMA Approval
The PCR-based test is designed to help in the selection of acute myelogenous leukemia patients eligible for certain treatments.
Qiagen Targets Oncohematology, Companion Diagnostics Space With Clinical Digital PCR Instrument
Premium
The firm launched the QiAcuityDx system on Monday and will seek US Food and Drug Administration 510(k) clearance along with a BCR-ABL assay.
Foundation Medicine, Syndax Pharmaceuticals Partner to Develop CDx for AML Treatment
The companion diagnostic assay, for a drug under development by Syndax, will identify acute myeloid leukemia patients with an NPM1 mutation.
Rarity Bioscience Building Oncology Test Portfolio on Highly Sensitive 'SuperRCA' Technology
Premium
The Swedish company is scaling up the production of targeted mutation assay kits and plans to release some of them for research use by the end of the year.
Mar 19, 2024
Sep 19, 2023
Sep 13, 2023
May 11, 2023